Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23157)

• Formulation Name: Eravacycline 50 mg For Injection
• Company: Tetraphase Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
TP-434	(DM5A31S)	Intra-abdominal infection	1A40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Hydrochloric acid	(E00015)	313	Acidulant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent